Take the Next Step Towards Parenthood
Speak with a fertility specialist today!
Embarking on the journey toward parenthood is a time of hope and anticipation, especially for those navigating the challenges of infertility. Advances in fertility treatments, such as in vitro fertilization (IVF), offer promising pathways to achieving this dream. While these advancements have revolutionized reproductive care, knowing and understanding how to manage potential risks is important, ensuring a safe and informed journey.
One such risk, Ovarian Hyperstimulation Syndrome (OHSS), although rare, requires awareness. This condition, linked with fertility treatments, involves the ovaries responding more vigorously than expected. However, with expert care and personalized treatment plans, the likelihood of experiencing severe OHSS is significantly minimized, ensuring that the path to parenthood remains hopeful and secure.
Ovarian Hyperstimulation Syndrome (OHSS) is characterized by overstimulation of the ovaries and triggered by a hormone called human chorionic gonadotropin (hCG) during fertility treatments. HCG’s use is for the final maturation of eggs in the ovaries before they are retrieved for fertilization in the lab.
When the ovaries are overstimulated, they can swell and become very vascular. Intravascular fluid can be lost through the ovary into the abdomen, pelvis, and other parts of the body, leading to symptoms such as bloating, abdominal pain, nausea, vomiting, and weight gain.
It’s essential to emphasize that severe OHSS is rare, affecting a very small percentage of individuals undergoing treatments like IVF.
Our clinic prioritizes patient education on OHSS symptoms to ensure early detection and management. Symptoms range from mild bloating and discomfort to more pronounced signs warranting medical attention. Early recognition of these symptoms allows for swift and effective interventions, mitigating discomfort and preventing progression.
The incidence of OHSS is low, with severe cases being extremely rare. Key factors such as age, specific medical conditions like PCOS, and the nature of the fertility treatment can influence risk levels. It affects approximately 3-6% of people who undergo IVF. Severe cases happen in less than 1% of people receiving fertility treatments.
A person is more likely to develop OHSS if they:
At RMA, our approach is rooted in prevention and personalized care. We meticulously tailor treatment protocols to each patient’s unique profile and follow you closely during your IVF cycle, significantly reducing the risk of OHSS.
To ensure safety and comfort, we employ innovative strategies for those at higher risk, including alternative medications and close monitoring. Our proactive measures, coupled with the latest advancements in fertility science, have made OHSS more manageable and less of a concern for aspiring parents.
While OHSS typically resolves within a few weeks, there are potential long-term effects to consider, especially in cases of severe OHSS.
These effects include:
Our commitment to your safety and well-being is paramount. We integrate the latest research and clinical guidelines into our practice, ensuring every patient receives the most advanced and personalized care possible, including:
The symptoms of OHSS vary depending on the severity of the condition.
Symptoms of mild OHSS include:
Symptoms of moderate to severe OHSS include:
Diagnosis of OHSS typically involves a physical exam, evaluation of symptoms, monitoring of hormone levels, and ultrasound imaging, among other tests.
Laboratory Tests
A fertility specialist may order the following laboratory tests to diagnose and evaluate OHSS:
Imaging Tests
In most cases, OHSS can be effectively managed with conservative treatment measures focused on symptom relief and supportive care.
Treatment options for mild to moderate OHSS may include:
At RMA, we prioritize the prevention of OHSS by implementing several precautions and preventive measures tailored to high-risk individuals.
These strategies aim to minimize the risk of OHSS while ensuring effective fertility treatments:
Pregnancy with a fresh embryo transfer can exacerbate the symptoms of OHSS for weeks. In addition, fresh embryo transfer has been demonstrated to have lower pregnancy rates than frozen embryo transfer and does not allow for Preimplantation Genetic Testing for Aneuploidy (PGT-A). At RMA, all of our transfers are done in a frozen embryo transfer cycle to increase your chance of success and lower your risk of OHSS.
By implementing these preventive measures, RMA demonstrates a commitment to minimizing the risk of OHSS and providing comprehensive care for all patients undergoing fertility treatments. Our proactive approach empowers patients to make informed decisions about their treatment plans and promotes a positive and safe fertility journey.
At RMA, we believe in empowering our patients with knowledge and options, enabling informed decisions every step of the way. OHSS, while an important consideration, is a manageable aspect of fertility treatments, with our team dedicated to ensuring your experience is as safe and positive as possible.
If you’re exploring fertility treatments or have questions about OHSS, we’re here to help. Our team of fertility specialists is committed to providing personalized consultations, addressing your concerns, and crafting a care plan that aligns with your dreams of parenthood.
Together, we can navigate the complexities of fertility treatments with confidence, supported by a foundation of expert care and compassion. Contact us to learn more about how we can help your journey to a happy, healthy pregnancy.
BELLEVUE, WA – March 13, 2024 – Reproductive Medicine Associates (RMA), one of the nation's…
While ovulation tests aren't magical crystal balls that can predict the exact moment of ovulation,…
Assisted reproductive technology (ART) provides hope and opportunity for individuals or couples struggling with infertility…
At-home fertility tests are becoming increasingly popular due to their convenience and affordability. They can…